Skip to main content

2023 PharmSci 360 Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Kirk Haltaufderhyde, Ph.D.

Scientist, Vaccines
EpiVax, Inc.

Poster(s):

(T1530-10-64) Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods

Tuesday, October 24, 2023
3:30 PM – 4:30 PM ET